Oncothyreon Inc. Announces Presentations at Upcoming Investment Conferences in November 2012

Published: Nov 08, 2012

SEATTLE, Nov. 7, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that management will be presenting at the following upcoming investment conferences in November.

Lazard Capital Markets 9th Annual Healthcare Conference
Wednesday, November 14, 2012, at 3:00 p.m. Eastern time in New York, NY

24th Annual Piper Jaffray Healthcare Conference
Tuesday, November 27, 2012, at 3 p.m. Eastern time in New York, NY

A live and archived webcast of each presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

SOURCE Oncothyreon Inc.

Back to news